| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. | Clin Exp Nephrol | 2007 | 1.47 |
| 2 | Zinc-finger transcriptional factor Sall1 induces angiogenesis by activation of the gene for VEGF-A. | Hypertens Res | 2009 | 1.42 |
| 3 | The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis. | Endocr J | 2011 | 1.13 |
| 4 | The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis. | Expert Opin Pharmacother | 2013 | 0.86 |
| 5 | Prolonged protective effect of short daily hemodialysis against dialysis-induced hypotension. | Kidney Blood Press Res | 2005 | 0.86 |
| 6 | Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis. | Nephron | 2002 | 0.81 |
| 7 | [Cytokine]. | Nihon Rinsho | 2004 | 0.75 |